Fingerprint
Dive into the research topics where Minghao Dang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy (Nature, (2025), 644, 8076, (537-546), 10.1038/s41586-025-09203-8)
Dai, Y., Knisely, A., Yano, M., Dang, M., Hinchcliff, E. M., Lee, S., Welp, A., Chelvanambi, M., Lastrapes, M., Liu, H., Yuan, Z., Wang, C., Nie, H., Jean, S., Montaner, L. J., Hou, J., Patel, A., Patel, S., Fellman, B. & Yuan, Y. & 21 others, , Sep 25 2025, In: Nature. 645, 8082, p. E10Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence
Soeung, M., Yan, X., Zanca, C., Qian, J., Karki, M., Duan, F., Khan, H., Zhang, L., Peng, D. H., Williams, M., He, R., Chen, Z., Perelli, L., Chen, J., Tidwell, R. S., Chauhan, P. K., Le, C. N., Lam, T. N. A., Bhattacharya, N. & Shah, R. & 46 others, , Dec 2025, In: Nature communications. 16, 1, 10474.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial
How, J. A., Dang, M., Lee, S., Fellman, B., Westin, S. N., Sood, A. K., Fleming, N. D., Shafer, A., Yuan, Y., Liu, J., Zhao, L., Celestino, J., Hajek, R., Morgan, M. B., Parra, E. R., Laberiano Fernandez, C. D., Arrechedera, C. A., Solis Soto, L. M., Schmeler, K. M. & Nick, A. & 4 others, , Jan 10 2025, In: Med. 6, 1, 100494.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
PPP2R1A mutations portend improved survival after cancer immunotherapy
Dai, Y., Knisely, A., Yano, M., Dang, M., Hinchcliff, E. M., Lee, S., Welp, A., Chelvanambi, M., Lastrapes, M., Liu, H., Yuan, Z., Wang, C., Nie, H., Jean, S., Montaner, L. J., Hou, J., Patel, A., Patel, S., Fellman, B. & Yuan, Y. & 21 others, , Aug 14 2025, In: Nature. 644, 8076, p. 537-546 10 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Scopus citations -
Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets
Moreno Rueda, L. Y., Wang, H., Akagi, K., Dang, M., Vora, A., Qin, L., Lee, H. C., Patel, K. K., Lin, P., Mery, D. E., Zhan, F., Shaughnessy, J. D., Yi, Q., Song, Y., Jiang, B., Gillison, M. L., Thomas, S. K., Weber, D. M., Diao, L. & Wang, J. & 4 others, , Feb 18 2025, In: Cell Reports Medicine. 6, 2, 101925.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations